Dashboard
Manage Tickers

MRKMerck & Co., Inc.

NYSE merck.com


$ 127.72 $ -0.18 (-0.14 %)    

Tuesday, 02-Jul-2024 15:40:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.17 $ 6.27 (1.31 %)
DIA $ 392.83 $ 1.99 (0.51 %)
SPY $ 548.08 $ 4.34 (0.8 %)
TLT $ 90.63 $ -0.04 (-0.05 %)
GLD $ 215.49 $ 0.21 (0.1 %)
$ 127.9
$ 128.18
$ 3.00 x 144
$ 127.75 x 104
$ 126.71 - $ 128.18
$ 97.23 - $ 134.63
11,532,966
na
323.95B
$ 0.32
$ 140.48
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mrna-technology-promises-to-make-a-long-time-coming-turning-point-in-cancer-treatment
mRNA Technology Promises To Make A Long-Ti...
07/02/2024 17:38:18

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame duri...

insights-into-merck-amp-cos-performance-versus-peers-in-pharmaceuticals-sector
Insights Into Merck & Co's Performance...
07/02/2024 15:00:39

5-biggest-winners-5-biggest-losers-from-dow-jones-industrial-average-in-first-half-2024
5 Biggest Winners, 5 Biggest Losers From D...
07/01/2024 22:38:43

Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best an...

whats-going-on-with-merck-stock-on-monday
What's Going On With Merck Stock On Monday?
07/01/2024 17:26:41

Merck secures exclusive global rights to develop and commercialize opevesostat (MK-5684/ODM-208) for hormone-dependent cancers....

market-whales-and-their-recent-bets-on-mrk-options
Market Whales and Their Recent Bets on MRK...
07/01/2024 15:47:10

merck-and-orion-announce-mutual-exercise-of-option-to-convert-opevesostat-co-commercialization-agreement-into-an-exclusive-global-license-for-merck-orion-now-eligible-for-development-milestones-up-to-30m-regulatory-milestones-up-to-625m-and-sales-milestones-up-to-975m
Merck And Orion Announce Mutual Exercise O...
07/01/2024 12:20:16

whats-going-on-with-merck-stock-on-friday
What's Going On With Merck Stock On Friday?
06/28/2024 12:39:32

The CDC's Advisory Committee on Immunization Practices recommends Merck's Capvaxive for adults 65+ and certain at-risk ...

the-committee-for-medicinal-products-for-human-use-of-the-european-medicines-agency-recommended-the-approval-of-mercks-winrevair-sotatercept-combined-with-other-pulmonary-arterial-hypertension-pah-therapies-for-pah-in-adult-patients
The Committee For Medicinal Products For H...
06/28/2024 11:02:41

, European Commission's Decision Is Expected In Q3 

Core News & Articles
Merck's Pneumonia Shot Recommended For Hea...
06/27/2024 20:54:35

- Bloomberg

a-closer-look-at-merck--cos-options-market-dynamics
A Closer Look at Merck & Co's Options Mark...
06/27/2024 19:49:25

Core News & Articles
CDC's ACIP Unanimously Votes To Add Merck ...
06/27/2024 19:40:39

- Reuters

fda-declines-to-approve-merck-daiichi-sankyo-partnered-lung-cancer-drug
FDA Declines To Approve Merck-Daiichi Sank...
06/27/2024 14:13:16

The FDA issued a Complete Response Letter for Daiichi Sankyo and Merck's BLA for patritumab deruxtecan targeting EGFR-mutat...

reported-earlier-fda-issues-complete-response-letter-for-daiichi-sankyo-and-mercks-lung-cancer-treatment-patritumab-deruxtecan-approval-delayed-by-fda-due-to-third-party-manufacturing-concerns
Reported Earlier, FDA Issues Complete Resp...
06/27/2024 07:13:05

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (...

beating-cancer-is-still-an-everything-but-easy-challenge-that-pharmaceutical-companies-cannot-solve-overnight
Beating Cancer Is Still An Everything-But-...
06/26/2024 15:29:20

On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threa...

merck--companys-merck-animal-health-received-approval-of-nobivac-nxt-canine-flu-h3n2-from-us-dept-of-agriculture
Merck & Company's Merck Animal Health Rece...
06/25/2024 20:06:30

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease

analyst-sees-keros-therapeutics-as-next-acceleron-set-for-major-biotech-growth
Analyst Sees Keros Therapeutics As Next Ac...
06/25/2024 18:43:19

Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation....

gossamer-bios-clean-safety-profile-differentiates-it-from-merck-analyst-says
Gossamer Bio's Clean Safety Profile Differ...
06/25/2024 18:39:14

Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary art...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

Core News & Articles
CORRECTION: Merck KGaA Ticker Is "MKGAF"
06/24/2024 17:06:47

5-biotech-stocks-with-key-catalysts-this-week-merck-intellia-verona-and-more
5 Biotech Stocks With Key Catalysts This W...
06/24/2024 08:51:47

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)